Anelixis Therapeutics
Cambridge
About Anelixis Therapeutics
Anelixis Therapeutics is a clinical stage development company located in Cambridge, Massachusetts with a portfolio focused on immune modulatory drugs for neurodegenerative diseases with a focus on amyotrophic lateral sclerosis (ALS) and Alzheimer's Disease (AD). Anelixis Therapeutics is committed to advancing treatments that will have a meaningful impact on the lives of patients by helping them battle back their disease progression.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $6.9M
- Funding stage: M&A
- Last round: Series Unknown (Apr 2018)
- Website: anelixistherapeutics.com
- Phone: +1.617.599.6514
Industries & Categories
Biotechnology, Clinical Trials, Medical, Product Research
Canonical: https://fsome.com/organization/anelixis-therapeutics-190768 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.